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In multiple myeloma plasma cells undergo uncontrolled  proliferation leading 
to production of a protein characteristic of each line of cells. As a result, a large 
amount of a homogeneous protein is elaborated into the serum, and small pro- 
tein molecules may be excreted in the urine as Bence Jones proteins.  Several 
observations suggest that the multiple myeloma proteins represent marked ele- 
vation  of individual  moieties  of normal gamma globulins  (1,  2).  Interest in 
these proteins has intensified  considerably as a  means of approaching various 
problems of normal gamma globulin and antibodies. 
Previous studies have demonstrated that gamma type multiple myeloma proteins 
have variable cross-reactivity with antisera to normal human gamma globulin  (3). 
The same study also provided evidence that the beta type multiple myeloma proteins 
cross-react with the same antisera, but to a much lesser degree. Subsequently, multiple 
myeloma proteins have been classified into groups 1, 2, and 3 on the basis of their 
cross-reactivity with antisera to normal human gamma globulin  (4).  The groups  1 
and 2 are gamma type myeloma proteins, whereby each group has antigenic deter- 
minants specific to the group. Group 3 in this system of classification  consists  of/3~x 
type multiple myeloma  proteins.The same investigators classified Bence Jones proteins 
into two groups, A and B, on the basis of their reactivity with antisera to normal hu- 
man gamma globulin  (5). 
It has been demonstrated  that  the  normal  7S  "y-globulin cross-rcacts  with  19S 
"y-globulin, pathological  macroglobulins,  /3~A myeloma proteins,  and  Bence  Jones 
proteins  and  that  the  cross-reacting  antigenic  determinants  of  7S  ~,-globulin  are 
located on the electrophoretically slow migrating fragments (subsequently called the 
S-fragments)  of  papain-digested  7-globulin  (6).  The  genetically  determined  Gin 
factors are located on the electrophoretically fast moving fragments of papain-digested 
v-globulin (subsequently called the F-fragments); whereas the Inv factors are located 
on the S-fragment of the 7S ~'-globulin and also on  the/3~x myeloma proteins, Bence 
Jones proteins, and  WaldenstrSm  type maeroglobulins  (7,  8).  Furthermore,  recent 
studies by Edelman and collaborators (9, 10) show that the light chains from multiple 
myeloma proteins, cleaved from the myeloma protein molecules by mercaptoethanol 
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in presence of urea, have precisely the same electrophoretic mobility on starch gel 
as the Bence Jones proteins from the same patients. All these studies indicate that 
certain subunits of 7S "r-globulin  molecules are also present in other immune globulins; 
i.e.,  the macroglobulins, ~sA proteins, and Benee Jones proteins. 
In the current investigation it was observed that the antigenic determinants 
which allow the classification of gamma type multiple myeloma proteins into 
two groups also exist on the smaller Bence Jones proteins, as well as on fl2A 
myeloma proteins and on Waldenstr6m type macroglobulins. As a  result, the 
analysis of these determinants permits the classification of all "immunoglobu- 
lins" into two major antigenic groups. In addition, evidence was obtained for 
a  specific antigenic relationship between the serum myeloma protein and the 
Bence Jones protein excreted by the same individual. 
Materials  and Methods 
Multiple Myeloma Proteins.--Sera were collected from patients with established diagnosis 
of multiple myeloma and stored at 4°C. The multiple myeloma proteins were isolated from 
other serum components by zone eiectrophoresis on starch medium (11). 
All multiple myeloma proteins were classified as gamma type or beta 2A type myeloma 
proteins by immunoelectrophoresis utilizing specific antisera  to 7S T-globulin and to /3~A- 
globulin  (12). 
Bence Jones Proteins.--24-hour urine specimens were collected from i~atients with the 
diagnosis of multiple myeloma. The heat test for Bence Jones proteins was performed on fresh 
urine (13). The entire urine specimen was filtered through No. 40 Whatman filter paper and 
then dialyzed against running tap water for 24 hours in Visking dialysis tubing (31/32 inch 
width). Subsequently the dialyzed urine was concentrated by pervaporization at 4°C through 
the dialysis membrane. Zone electrophoresis on starch  medium (11) was utilized to obtain 
further purification of Bence Jones proteins. 
The specimens with  negative heat  test for Bence Jones proteins  on native urine were 
concentrated as described above. Subsequently small molecular weight proteins were isolated 
from these concentrated specimens by sucrose density gradient ultracentrifugation  (14) and 
then utilized for immunological studies. 
Macrogfobulins.--Serum was obtained from patients with Waldenstr6m type macroglobuli- 
nemia and stored at 4°C. The diagnosis of macrogiobulinemia was established either by the 
presence of 19S or heavier serum protein components in excess of 15 per cent of the total 
protein or by immunoelectrophoresis utilizing specific antisera to macroglobulins (12). 
Two preparative  steps were employed to  obtain pure preparations  of macroglobulins. 
Initially euglobulin was precipitated  by diluting the serum with cold distilled water or cold 
phosphate buffer (pH 5.8; 0.2 M Na2HPO4; 0.1 M citric acid) in 1:15 ratio. The precipitated 
proteins were dissolved in 0.85 per cent sodium chloride solution. Some macroglobulins were 
initially  isolated by zone electrophoresis on starch medium (11). Subsequently all preparations 
were subjected to density gradient ultracentrifugation in Spinco L centrifuge (14). Only the 
bottom fractions with macroglobulins were utilized for immunological studies. 
Antisera.--Antisera  to  7S v-globulin were produced by hyperimmunizing rabbits with 
pooled human fraction II and complete Freund's  adjuvant by subcutaneous weekly injections 
of 2 to 3 mg of fraction  II over a 4 month period. Antisera to Bence Jones proteins were 
produced in similar manner by injecting rabbits subcutaneously with the electrophoretically 
isolated proteins and complete Freund's adjuvant over a 10 week course of weekly injection. 
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with  two  fl2A myeloma proteins of different  antigenic groups  and subsequently absorbing 
these antisera with the serum  of a  person  with  congenital  absence of /~2A-globulins (15). 
Antisera specific to macroglobulins were produced by immunizing rabbits with a Waldenstr6m 
type macroglobulin  and  subsequently  absorbing  these  antisera  with  7S  normal  human 
"y-globulin. 
Agar Diffusion.--Ouchterlony agar diffusion studies (16) were  performed  in 2.0 per cent 
agar (agar agar from Baltimore Biological Laboratory, Baltimore)  in barbital buffer pH 8.6, 
ionic strength 0.05. Each antigen well received 0.25 mg of protein, and the antibody wells 
were filled with the antisera as indicated. At least 72 hours of incubation at 37°C was required 
prior to the final interpretation of the precipitin lines. 
Immunoelectrophoresis  was carried out as previously described (17) 
Precipitir~ Curves.--For construction of precipitin curves  the desired  aliquot of antigen 
solution was brought to a volume of 0.2 ml with saline, and 0.1 ml of antiserum was added. 
The mixture was left at room temperature for 1 hour, and then stored overnight at 4°C. On 
the following day the precipitate was separated by centrifugation at 3000 m~r at 4°C. The 
precipitate was washed three times with cold saline and then dissolved in 0.1 N NaOH. The 
protein was determined by the Folin-Ciocalteu method (18). 
The results reported in this study were obtained with pooled antiserum (No. 528) to 7S 
normal human ")'-globulin from a single rabbit, a very potent antiserum with broad reactivity 
with different antigenic determinants on the "y-globulin  molecule. However, similar results were 
obtained with other antisera in a sufficient number of experiments  to demonstrate that the 
findings were not peculiar to antiserum No. 528. In the precipitin studies the complement in 
antisera was inactivated by heating to 56°C for 30 minutes. 
RESULTS 
Studies on Gamma Type Multiple Myeloma Proteins.--Serum and urine speci- 
mens were investigated in twenty-one patients with multiple myeloma. Four- 
teen of these cases had gamma type  myeloma proteins (in figure legends and 
tables  called  MM  proteins)  in  the  serum  as  determined  by  immunoelectro- 
phoresis. In four instances Bence Jones proteins  (in figure legends and  tables 
called BJ  proteins)  were  present  in  urine  without  a  myeloma protein in  the 
serum.  In three cases the serum protein peak was found to be a  beta 2A type 
myeloma protein as revealed by immunoelectrophoresis; the latter three will be 
discussed under  a  separate heading. 
Multiple myeloma proteins of the gamma  type were readily  classified into 
groups  on  the  basis  of  their  reactivity with  antisera  to  normal  human  7S 
")'-globulin, as has been  described previously (4).  With such  antisera  in  agar 
diffusion studies the normal human -y-globulin spurred over group  1 and group 2 
myeloma proteins, with a small spur over group 1 proteins and with a large spur 
over group 2 proteins. Representative proteins of the  two  groups spurred over 
each other, thus indicating different antigenic determinants on the proteins of 
each group and the presence of both determinants on normal human "),-globulin 
in  variable proportions.  These  observations  are illustrated in  Fig.  1.  On  the 
basis  of  such  studies  the  gamma  type  myeloma  proteins  were  divided  into 
group  1 and group 2; ten in the former and five in the latter group  (see Table 
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FIG.  1.  Ouchterlony plate illustrating the antigenic difference between group 1 and group 2 
gamma type multiple myeloma proteins. Central well A  contains antiserum to 7S ~'-globulin. 
Wells 1 and 4 contain human fraction  II, well 2 a myeloma protein of group  2 (Spi.), and well 
3,  a  myeloma protein of group  1 (Roy.). 
TABLE  I 
Summary of Analyses Performed on Gamma Type Myeloma Proteins and Bence Jones Proteins 
from the Same Individuals 
Type of MM  Heat test on 
Patient  protein  urine 
Cia.  "y-type  Neg. 
Ger.  "  " 
Haa.  "  " 
Haw.  "  Pos. 
Pat.  "  " 
Roy.  "  " 
Sel.  "  " 
Sol.  "  Neg. 
Tan.  "  Pos. 
Wel.  "  Neg. 
Fri.  "  Pos. 
Kan.  "  " 
Nie.  "  Not avail. 
Spi.  "  Pos. 
Szo.  ~'  ~ 
Cu.  Absent  Pos. 
DeM.  "  " 
Fie.  "  " 
Pro.  "  " 
Group  Group of BJ  Antibody  ppt'd,  at  of MM 
equivalence  protein  protein 
~g 
640 
590 
660 
590 
600 
530 
620 
550 
640 
Mean  602  #g 
SD 40.5 
38O 
400 
4O0 
420 
Mean  400  #g 
SD 18.9 
m 
Not 
Reaction betweee 
BJ protein and 
antiserum ab- 
sorbed with 
autologous MM 
protein 
1  0 
1  0 
1  0 
1  0 
2  + 
1  0 
1  0 
1 
1  0 
1  0 
2  0 
2 
avail.  Not avail. 
2  0 
2  0 
1 
1 
2 
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Antigenic dissimilarity between group 1 and group 2 myeloma proteins was 
demonstrable  further  by  quantitative  precipitin  curves.  Typical  precipitin 
curves with pooled 7S human "y-globulin and representatives of the two groups 
of myeloma proteins are depicted in Fig.  2.  The pooled fraction II gave the 
highest number of micrograms of protein precipitated at equivalence. The repre- 
sentative of group  1 myeloma proteins gave  an intermediate  value,  and  the 
representative of  group 2  myeloma proteins  precipitated the least amount of 
protein. The micrograms of antibody protein precipitated by various myeloma 
S_ 
o_ 
.% 
c 
(D 
0 
CL 
C~ 
I000 [ 
/ 
.~  (i)  800  ,. 
iii[ : 
200 f 
i  I  I 
I00  200  300 
jug  of antigen 
FIG. 2.  Precipitin curves demonstrating the antigenic difference  between groups 1 and 2 
gamma type myeloma proteins• Anti-TS human "y-globulin  was reacted with pooled human 
fraction II (curve 1), with a myeloma protein of group 1 (curve 2), and with a myeloma 
protein of group 2 (curve 3). 
proteins at equivalence are recorded in Table I with their means and  standard 
deviations. 
In addition, the grouping of gamma type multiple myeloma proteins could 
effectively be carried out with antisera to Bence Jones proteins. The antiserum 
to a group 1 Bence Jones protein (DeM.) reacted only with multiple myeloma 
proteins belonging to group  1 and not with myeloma proteins from group 2. 
Similarly,  the  antiserum  to a  group 2  Bence Jones protein  (Spi.)  recognized 
myeloma proteins from group 2 and did not react with proteins from group 1, 
as illustrated in Fig. 3 by agar diffusion experiments. However, as seen in the 
lower half of Fig.  3,  the antiserum to a  group  1 Bence Jones protein did not 
react equally well with all group 1 proteins; two myeloma proteins of group 1 864  CLASSIFICATION OF  MYELOMA PROTEINS 
spur  slightly  over  the  protein  of Ger.,  also  a  group  1  gamma  type myeloma 
protein. 
On the basis of previous work, it was thought that the antigenic determinants 
of myeloma proteins that allow the grouping of these proteins are located on the 
S-fragments  of  the  papain-digested  myeloma protein  molecules.  To  test  this 
hypothesis, an antiserum to normal human 3,-globulin was absorbed at antigen 
excess  with  the  F-fragments  and  with  the  S-fragments  of  papain-digested 
FIG. 3.  Ouchterlony plate illustrating  the reactivity  of group 1 and group 2 gamma type 
myeloma proteins  with  antisera  to Bence Jones  proteins.  Well A  contains  antiserum  to a 
group 2 Bence Jones protein  (Spi.), and well B contains antiserum to a group 1 Bence Jones 
protein (DeM.). Wells 1 to 3 contain group 2 myeloma proteins (Kan., Szo., Fri. respectively) 
and wells 4 to 6 contain group 1 myeloma proteins (Roy., Ger., Tan. respectively). 
3,-globulin.  The upper half of Fig. 4  shows an agar diffusion experiment  with 
representatives  of the  two groups of gamma type myeloma proteins  spurring 
over each other and the 7S ~/-globulin spurring over both groups with the anti- 
serum absorbed with F-fragments. The precipitin lines  in the upper half of the 
figure are heavy and broad because the plate was incubated for 96 hours to allow 
maximal  time for the development of spurs in the lower half of the plate.  The 
spur of normal 7S 3'-globulin over the group 1 protein Wel, is not well seen in the 
illustration.  On the other hand,  if the same antiserum  was absorbed  with  the 
S-fragments, the same myeloma proteins and normal 3,-globulin show complete 
identity as seen on the lower half of Fig. 4. To obtain additional support for the 
observation  that  the  group specificity of myeloma proteins  is  located  on  the MART  MANNIK  AND  HENRY  G.  KUNKEL  865 
S-fragments  of the parent proteins,  multiple myeloma proteins  Spi.,  Ger., and 
Roy.  were digested  with  papain  (19).  In agar diffusion  experiments  the  group 
specificity was again present on the S-fragments,  and the F-fragments of these 
proteins  were identical. 
Studies on Bence Jones  Proteins and Their Relationship to A utologous Myeloma 
Proteins.--The presence of classical Bence Jones protein in the urine was ascer- 
FIG. 4.  Ouchterlony  plate  demonstrating  that  the  antigenic  specificities  of  multiple 
myeloma proteins  are localized to the S-fragments.  Well A contains anti-TS "y-globulin serum 
absorbed with F-fragments of normal human y-globulin,  well B contains  the same antiserum 
absorbed  with  S-fragments  of normal human  "y-globulin. The upper  and  lower  peripheral 
wells contain:  1, group  1 MM protein (Roy.); 2, group 2 MM protein (Spi.); 3, group  1 MM 
protein (Ger.);  4, fraction II; 5, group  1 MM protein (Wel.); 6, group 2 MM protein (Szo.). 
tained  by heating  the  native  urine  after  adjusting  the  pH  to 4.9  4-  0.1  (13). 
Seven of the  twenty-one  specimens gave a  negative  test for Bence Jones  pro- 
teins. The classical Bence Jones proteins as well as the isolated small molecular 
weight proteins from urines with negative heat tests were subjected to immuno- 
logical studies described below.  In this  section of the study,  and subsequently, 
the  two  groups  of Bence  Jones  proteins  will  be  termed  group  1  (formerly B) 
and group 2  (formerly A) for reasons stated  below. 
The  antiserum  to  Bence  Jones  protein  DeM.  (group  1)  reacted  only  with 
other  Bence Jones  proteins  from group  1,  and  not  with  Bence  Jones  proteins 866  CLASSIFICATION  OF  MYELOMA  PROTEINS 
from group 2.  On the other hand,  the  antiserum  to Bence Jones protein  Spi. 
(group 2) reacted only with other Bence Jones proteins from group 2 and not 
with group 1 proteins. These observations are illustrated in Fig. 5. In addition, 
the agar diffusion experiments  in Fig. 5  show that the Bence Jones protein to 
which the antiserum  has been directed  spurs over other Bence Jones proteins 
FIG. 5.  Ouchterlony plate illustrating  the recognition of Bence Jones proteins of group  1 
(B) and group 2 (A) by antisera directed to Bence Jones proteins of these two groups. Central 
well A contains antiserum to a group 2 BJ protein (Spi.), and central well B contains antiserum 
to a group 1 BJ protein  (DeM.). Peripheral wells 1 to 3 contain group 2 BJ proteins  (Spi., 
Szo., and Fri. respectively), peripheral wells 4 to 6 contain group 1 BJ proteins (DeM., Cum., 
and Roy. respectively). 
from the same group. This observation indicates that each Bence Jones protein 
has  specific  antigenic  determinants  as  well  as  determinants  in  common with 
other members of the same group. 
Previously recorded observations show that representatives of the two groups 
of Bence Jones proteins spur  through each other when tested  with antisera  to 
7S ~,-globulin (5). Therefore, it was thought that such antisera could be utilized 
to group the Bence Jones proteins. An antiserum to 7S ~/-globulin was absorbed 
at equivalence or at antigen excess with a  group 2 myeloma protein. This  ab- 
sorbed antiserum reacted only with Bence Jones proteins from group 1 and not 
with proteins from group 2. Furthermore,  if the same antiserum was absorbed 
with  a  myeloma protein  from group  1,  it  reacted  with  Bence Jones  proteins 
from group  2  and not with group  1 proteins.  Immunoelectrophoretic  experi- MART  MANNIK  AND  HENRY  G.  KUNKEL  867 
merits of this  type are illustrated  diagrammatically in  Fig.  6.  The precipitin 
lines parallel to the antibody troughs indicate that the absorption was carried 
out at antigen excess. 
Table I  shows that nine of the patients with group 1 gamma type myeloma 
proteins in serum excreted group 1 Bence Jones protein in their urine. The case 
of Pat. formed an exception to this rule. Four patients with group 2 gamma type 
myeloma protein in serum excreted group 2 Bence Jones proteins in urine. Pa- 
tients  without  a  serum multiple myeloma protein  excreted either  group  1 or 
group 2 Bence Jones proteins. 
Since  the  above observations indicated  that  the multiple myeloma protein 
and the Bence Jones protein of a patient have certain common antigenic deter- 
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FIG. 6.  Diagram of immunoelectrophoresis illustrating  the  recognition of Bence Jones 
proteins by antiserum to 7S normal ")'-globulin  absorbed with a MM protein of the opposite 
group. Trough A, antiserum to 7S human "/-globulin absorbed with a MM protein of group 1; 
trough B, same antiserum absorbed with a MM protein of group 2. Well 1 contains a BJ 
protein of group 1 (Roy.) and well 2 contains a BJ protein of group 2 (Spin.). 
minants,  further  investigation of the relationship between  these proteins was 
undertaken. Antiserum to normal 7S human "y-globulin was absorbed at equiva- 
lence or antigen excess with the myeloma protein of a patient. Subsequently the 
corresponding  Bence  Jones  protein  was  tested  with  the  absorbed  antiserum. 
The myeloma proteins  (see Table I) removed antibodies reactive with the au- 
tologous Bence Jones proteins with the exception of Pat. Diagrams of such im- 
munoelectrophoretic studies are given in Fig. 7. The antiserum to 7S 3,-globulin 
was  also absorbed  at antigen excess with the myeloma protein of Pat. As seen 
in  Fig.  7,  this  absorbed antiserum still reacted with  the isolated Bence Jones 
protein of Pat.,  but not with group 1 Bence Jones proteins.  It is noteworthy 
that in this single case the Bence Jones protein group did not correspond to the 
serum myeloma protein group. In additional experiments antisera to individual 
Bence Jones proteins were absorbed at antigen excess with the myeloma pro- 
tein from the same patients. After absorption these antisera failed to react with 
Bence Jones proteins to which they had been directed. 
Studies on ~2A Multiple Myeloma Proteins and Their Autologous Bence Jones 
Proteins.--Preliminary  studies  with  isolated  beta 2A  type myeloma proteins 868  CLASSIFICATION  OF  MYELOMA  PROTEINS 
showed that these proteins fell into two groups on the basis of their reactivity 
with antisera to 7S normal "v-globulin. This is illustrated in Fig. 8. The beta 2A 
type myeloma proteins from opposite groups  spurred  through  each  other  in 
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FIG. 7.  Diagram of immunoelectrophoresis illustrating  the  antigenic similarity between 
the MM protein and the BJ protein from the same patient. Trough A contains antiserum to 
7S human ~/-globulin, trough  B  the same antiserum absorbed with MM protein  of Roy, 
trough C the same antiserum absorbed with MM protein of Szo., and trough D the same 
antiserum absorbed with MM protein of Pat. Well 1 contains the BJ protein of Roy., well 2 
the BJ protein of Szo., well 3 the MM protein of Pat., and well 4 the BJ protein of Pat. 
FIG. 8.  Ouchterlony plate  illustrating  the differences between the group 1 and group 2 
f12~. myeloma proteins. Central well A contains an antiserum to 7S human "y-globulin.  Periph- 
eral wells 1 and 2 contain group 2 /32A MM proteins (Blo. and LuD. respectively) and wells 
3, 4, and 5 contain group 1/~2A MM proteins (Cot., Bern., and McC. respectively). 
Ouchterlony  diffusion  experiments,  whereas  representatives  of  each  group 
showed  complete identity. For  this  reason further  study was  undertaken to 
clarify the relationship of the two groups of beta 2A type myeloma proteins to 
the two antigenic groups of gamma type myeloma proteins. 
An antiserum to 7S normal human ~-globulin was absorbed with a  group 1 MART  MANNIK  AND  HENRY  G.  KUNKEL  869 
gamma  type  myeloma  protein.  This  absorbed  antiserum  reacted  only  with 
group  2  gamma  type  and  group  2  beta  2A  type  myeloma proteins,  showing 
complete identity of the group-specific antigenic determinants of the gamma and 
beta 2A type proteins of this group. The same antiserum was absorbed with a 
group 2  gamma type myeloma protein.  This  absorbed antiserum  reacted only 
FIG. 9.  Ouchterlony plate  demonstrating  the grouping of/32A myeloma proteins.  Well A 
contains an antiserum to human 7S "/-globulin absorbed with a group 1 "/type MM protein 
(Roy.), and well B contains the same antiserum  absorbed with a group 2 gamma  type MM 
protein  (Spi.). Peripheral wells 1 and 4 contain a group 1 fl2A MM protein  (Born.), wells 3 
and 6 a group 2 fl2A MM protein  (LuD.), well 2 a group 1 gamma type MM protein  (Roy.), 
and well 5 a group 2 gamma type MM protein  (Spi.). 
with group 1 gamma type and group 1 beta 2A type myeloma proteins, showing 
complete identity of the group-specific antigenic determinants of the gamma and 
beta  2A type myeloma proteins.  These  observations  are  illustrated  in  Fig.  9 
with agar diffusion experiments.  Of the eleven isolated beta 2A type myeloma 
proteins five belonged to group 1 and six to group 2  (Table II). 
The typing of beta 2A type myeloma proteins was also performed with anti- 
sera to Bence Jones proteins. The antiserum  to a  group 1 Bence Jones protein 
(DeM.)  reacted  with  group  1  beta  2A  type  myeloma proteins  and  not with 
group 2 proteins.  On the other hand,  an antiserum  to a  group 2 Bence Jones 870  CLASSIFICATION OF  MYELOMA  PROTEINS 
protein (Spi.) reacted with group 2 beta 2A type proteins and not with group 1 
proteins. 
In three patients with beta 2A type multiple myeloma, urine specimens were 
available.  One  of  these  contained  classical Bence  Jones  proteins.  The  three 
urine proteins belonged to group 2,  corresponding to the group of the serum 
myeloma protein. The number of urine proteins investigated in beta 2A type 
multiple myeloma cases is small, but the same relationship appears to hold true 
as was observed in patients with gamma type multiple myeloma; i.e., the anti- 
TABLE  II 
Grouping of ~A Mydoma Proteins and Macroglobulins by Two Different Procedures 
~2A myeloma proteins  Macroglobulins 
Grouping based  Grouping based  Grouping based 
on reaction with  on reaction with  on reaction with  Grouping  based 
Patient  antisera to two  Patient  antisera to two  on reaction with 
types of BJ  anti-sera to  types of BJ  antisera to 
normal ~,-globuli~  normal T-globulin  proteins  proteins 
Bom. 
Cot. 
Gou. 
McC. 
Xis. 
Blo. 
Cou.* 
Eis. 
LuD. 
Sam.* 
Zah.* 
Bem. 
Bot. 
Car. 
Deu. 
Rye. 
Wok 
Zam. 
Fog. 
Gin. 
Lic. 
Lyn. 
Ran. 
Ste. 
* The urine from Cou., Sam., and Zah. contained group 2 Bence Jones proteins. 
genic group of the serum multiple myeloma protein corresponds to the antigenic 
group of the Bence Jones protein in individuals. 
Studies  on  Waldenstr6m type macroglobulins.--Since  common group-specific 
antigenic  determinants  were  observed in  this  study  in  gamma and  beta  2A 
type myeloma proteins and in Bence Jones proteins, it was thought that these 
determinants should also be present on the WaldenstrSm type macroglobulins, 
particularly in that the latter proteins cross-react with  the S-fragments of 7S 
gamma globulin (6). 
Indeed, the Waldenstr6m type macroglobulins could be categorized into two 
groups by their reactivity with antisera to Bence Jones proteins. Antiserum to 
a  group  1 Bence Jones protein  (DeM.)  reacted with only a  group of isolated 
macroglobulins,  subsequently  termed  group  1.  This  antiserum  did  not  react MART  MANNIK  AND  HENRY  G.  KUNKEL  871 
with  other macroglobulins.  On the other hand,  antiserum  to a  group 2  Bence 
Jones protein  (Spi.)  reacted only with  those macroglobulins that did not react 
with the antiserum  to a group 1 Bence Jones protein. The latter group of Wal- 
denstr6m type macroglobulins will be subsequently termed group 2. These find- 
ings are illustrated  in Fig.  10  and tabulated  in Table II. 
Additional experiments were conducted to establish the identity of the group- 
FIo. 10. Ouchterlony plate demonstrating  the grouping of Waldenstr6m type macroglobu- 
lins with antisera  to Bence Jones proteins.  Central  well A contains antiserum  to a group 2 
Bence Jones protein  (Spi.) and well B contains antiserum  to a group 1 Bence Jones protein 
(DeM.). Peripheral wells 1 to 3 contain group 2 macroglobulins (Lyn., Fog., and Ste. respec- 
tively) and wells 4 to 6 contain group 1 macroglobulins (Bern., Bot., and Zam. respectively). 
specific antigenic determinants  on macroglobulins with the group-specific deter- 
minants on gamma type myeloma proteins. An antiserum to 7S normal "},-globu- 
lin was absorbed with the F-fragments of normal gamma globulin to avoid spur 
formation of the gamma type myeloma proteins over macroglobulins due to the 
antigenic determinants of the F-fragments of the myeloma proteins. The results 
of  these  experiments  with  double  diffusion  in agar are  illustrated  in  Fig.  11. 
This illustration shows that a group 1 WaldenstrSm type macroglobulin is iden- 
tical  with  a  group  1  gamma  type  myeloma protein  in  regard  to  the  group- 
specific antigenic determinants,  but reaction of non-identity is seen between a 
group 1 macroglobulin and a  group 2 gamma type myeloma protein.  Similarly 
a  group 2 macroglobulin shows identity with  a  group 2 gamma type myeloma 872  CLASSIFICATION OF MYELOMA  PROTEINS 
protein and non-identity with a  group  1 gamma type myeloma protein. From 
these  observations,  it  is  apparent  that  representatives  of  the  two  groups  of 
WaldenstrSm  type  macroglobulins  should  spur  through  each  other  with  an 
antiserum to 7S 3,-globulin. This was not observed in the studies demonstrated 
in the upper part of Fig.  11, possibly due to dilution of antiserum during ab- 
sorption.  However,  using  an  unabsorbed  potent  antiserum  to  7S  T-globulin, 
FIG. 11.  Ouchterlony  plate illustrating the identity of group  1 and group  2 determinants 
in macroglobulins and in gamma type myeloma proteins.  In the upper half of this figure the 
central well A contains an antiserum to human 7S 3"-globulin absorbed with F-fragments of 
papain-digested human fraction II. Peripheral well 1 contains a group  1 (Roy.) gamma type 
MM protein, wells 2 and 5 a group  2 macroglobulin  (Ste.), wells 3 and 6 a group  1 macro- 
globulin  (Bem.), and well 4 a group 2 (Spi.) gamma type MM protein. In the lower half of 
this figure the central well B contains an antiserum to 7S 3'-globulin. Peripheral wells 1 and 2 
contain group  1 macroglobulins  (Bem. and Zam.) and 3 a group 2 macroglobulin  (Ste.). 
this could be brought out as shown in the lower half of Fig.  11. The Walden- 
strSm  type  macroglobulins  from  the  two  groups  spurred  over  each  other, 
whereas two proteins from the same group showed complete identity with this 
antiserum. 
The  cross-reaction between  normal  7S  T-globulin  and  WaldenstrSm  type 
macroglobulins  is  not  confined  to  the  group-specific antigenic  determinants 
described above. This was observed by absorbing an antiserum  to normal 7S 
~,-globulin with Bence Jones  proteins of both antigenic groups.  Such antisera 
still reacted  with  the  isolated macroglobulins, but  failed to  demonstrate  the 
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Urine proteins from patients with Waldenstr6m type macroglobulinemia were 
not available for analysis. 
DISCUSSION 
Previous observations have indicated  that  through  the use of antisera  to 
normal human gamma globulin the gamma type myeloma proteins could be 
classified into two major groups (termed 1 and 2)  (4). By similar studies also 
Bence Jones proteins fell into two groups (termed A and B) (5). The present 
investigations indicate  that  the antigenic  determinants  involved in grouping 
of gamma type myeloma proteins and Bence Jones proteins are actually the 
same. Antisera to isolated Bence Jones proteins proved to be particularly useful 
for the classification  of the two groups of gamma type myeloma proteins and 
the  two groups of Bence Jones proteins.  Equally useful for classification  of 
these proteins were antisera to normal human gamma globulin absorbed with 
a myeloma protein of the opposite group. Since the antigenic determinants on 
gamma  type myeloma proteins and Bence Jones proteins are the same,  it is 
recommended  that  the group  1 and  2 nomenclature,  originally used for the 
gamma myeloma proteins, be employed as well for the Bence Jones proteins. 
Further, it was demonstrated that the group-specific antigenic determinants of 
gamma type myeloma proteins are located on the S-fragments of the molecule. 
In addition, the F-fragments of myeloma proteins and normal human 7-globu- 
lin  showed  antigenic  identity.  However,  the identity of  the F-fragments  of 
gamma  type myeloma proteins  is  ouly antigenic.  Starch  gel  electrophoretic 
studies  of  enzymatically degraded  ^/-type  proteins  from  mouse  plasma  cell 
tumors show several distinct bands of F-fragments (20).  Furthermore, the Gin 
genetic factors, present on the F-fragments of gamma type myeloma proteins 
(7), show variation among these proteins (21). 
Analyses of isolated beta 2A type myeloma proteins and purified Walden- 
str6m type macroglobulins demonstrated that these, too, fell into two antigenic 
groups based on the presence of the determinants permitting  the grouping of 
gamma type myeloma proteins and Bence Jones proteins. For this reason the 
two groups of beta 2A type myeloma proteins and the two groups of Walden- 
str6m type macroglobulins should be designated as group 1 and group 2. The 
grouping of these proteins was also most effectively performed by antisera to 
isolated Bence Jones proteins or with antisera to normal gamma globulin ab- 
sorbed with a gamma myeloma protein of the opposite antigenic group. Previous 
studies indicated that at least two groups of beta 2A myeloma proteins existed 
(22, 23). Although reported investigations have demonstrated antigenic differ- 
ences among the Waldenstr6m type macroglobulins (24),  the two major anti- 
genic groups had not been described. 
The  present  studies  indicate  that  two fundamental  antigenic  types  exist 
among gamma and beta 2A type myeloma proteins, Bence Jones proteins, and 874  CLASSIFICATION  O]~ MYELOMA  PROTEINS 
Waldenstrt~m  type macroglobulins,  based on the presence of one of the two 
mutually exclusive  antigenic determinants  on these proteins.  At the present 
time the significance of this basic difference is not apparent. 
It should be emphasized that this grouping,  although clear  cut in most in- 
stances, represents somewhat of an oversimplification.  Additional minor groups 
probably exist, and subgroups may become evident among these proteins with 
further analysis. Fig. 4 indicates that a group 1 myeloma protein (Ger.)  does 
not react with the antiserum to a group I Bence Jones protein as well as the 
two other  adjacent  group  I  myeloma proteins.  Similarly,  occasional minor 
spurs were noted among the group 1 myeloma proteins in certain samples not 
included in this investigation. The clarification  of this point requires a thorough 
study of a much larger series of multiple myeloma proteins and Waldenstr~m 
type macroglobulins. 
The present studies offer evidence that a patient with gamma type multiple 
myeloma protein in the serum excretes Bence Jones proteins in urine that cor- 
respond in antigenic grouping to the antigenic group of the serum myeloma pro- 
rein.  Furthermore, a myeloma protein contains all the antigenic determinants 
present on the corresponding Bence Jones protein as determined by antisera to 
normal human ~'-globuIin  and with antisera  to Bence Jones proteins.  These 
results  are in agreement with  the recent observations of Edelman  and  col- 
laborators (9, I0) on the correspondence between the Bence Jones proteins and 
the light chains cleaved from the myeloma proteins by mercaptoethanol in the 
presence  of  urea  as  revealed by starch  gel  electrophoresis.  Several  of  the 
myeloma protein-Bence Jones protein combinations used in this  study were 
also Included in the latter investigation. Where correspondence was noted be- 
tween the light chains of a  myeloma protein and the Bence Jones protein on 
starch gel electrophoresis,  also antigenic similarity was observed. The one ex- 
ception reported by Edelman (I0) also showed a lack of antigenic correspond- 
ence between the Bence Jones protein and the serum myeloma protein (Pat. 
Table I, Fig.  7). In addition, the preliminary report by Putnam eta/.  (25) on 
tryptic hydrolysates of myeloma proteins and the corresponding Bence Jones 
proteins separated on two dimensional  chromatography has disclosed that the 
peptides of Bence Jones proteins are precisely superimposed on some of the 
peptides of the corresponding myeloma proteins, and that a Bence Jones pro- 
tein does not contain peptides not present in the corresponding myeloma pro- 
tein. One exception was also noted in their study. Thus the present immuno- 
logical  studies  and  other  physicochemical  investigations  described  above 
indicate that the Bence Jones proteins are closely related to the corresponding 
myeloma proteins and a portion of the myeloma protein behaves antigenicaUy 
and physicochemically like the Bence Jones protein. The most striking evidence 
for this was provided by the demonstration that light chains  isolated from a 
myeloma protein behaved like Bence Jones proteins from the same patient in 
being altered reversibly by heating  (10). MART  MANNIK  AND  HENRY  G. KUNKEL  875 
Only a limited number of Bence Jones proteins from patients with beta 2A 
multiple myeloma were available. Nevertheless, grouping of the Bence Jones 
proteins appears to correspond to the grouping of the serum myeloma protein. 
Urine from patients with Waldenstr6m type macroglobulinemia was not avail- 
able for analysis. In one reported case the Bence Jones protein from such a pa- 
tient was typed as group A (group 2), and from the data presented, the macro- 
globulin probably can be classified as from group 2 (24). It is predicted that the 
Bence Jones proteins from patients with Waldenstr6m type macroglobulinemia 
will fall into two groups similar to Bence Jones proteins from multiple myeloma. 
The  observation  that  in  double diffusion  in  agar  normal  human  gamma 
globulin spurs over representatives of group 1 and  group 2 gamma type mye- 
loma proteins with an antiserum to normal 7-globulin suggests that the anti- 
genlc determinants allowing the grouping of myeloma proteins are also present 
in normal human -},-globulin, and on account of the varying intensity of spurs, 
perhaps in differing  proportions. Indeed, studies to be reported separately in 
detail disclosed that approximately 60 per cent of normal 7-globulin molecules 
carry the antigenic  determinants  of group  1 and  30 per cent  the antigenic 
determinants  of group 2 myeloma proteins  (26,  27).  The latter observations 
further demonstrate the ubiquity of the two antigenic determinants among the 
immunoglobulins.  The significance of these antigenic differences in normal 7S 
"},-globulin and their relationship to the production of various antibodies remain 
to be clarified. 
SUMMARY 
Antisera  to normal  7S 7-globulin and  to Bence Jones proteins permit the 
grouping of myeloma proteins (gamma and beta 2A types), Bence Jones pro- 
teins,  and the Waldenstrtim  type macroglobulins into two fundamental anti- 
genic groups.  The  antigenic  determinants  responsible for  this  grouping  are 
common to all these proteins which fall in the general category of immuno- 
globulins.  Antisera  to Bence Jones proteins were particularly useful for this 
classification  since they failed to react with the proteins of the opposite group. 
These antisera  also  permit the  grouping  of normal  7S  -r-globulin  into  two 
major types. 
The Bence Jones proteins from individual patients were found to correspond 
in antigenic group to that of the serum myeloma protein. Studies with antisera 
to 7S 7-globulin and to Bence Jones proteins indicated that the Bence Jones 
proteins were antigenically identical to a portion of the corresponding multiple 
myeloma protein molecules. 
The authors wish to thank Dr. Robert W. Carey for generously providing several of the 
serum and urine specimens from patients with multiple myeloma. 
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